COVID-19 Information for Sponsored Programs

During COVID-19, the Office of Sponsored Programs (OSP) plans to be fully operational.

The Office of Sponsored Programs (OSP) is currently fully operational. In response to the COVID-19 Pandemic, OSP will be working from home beginning March 16, 2020 until further notice. OSP staff continue to be available by email and phone, and our main line (412-624-7400) can also be used. Transaction requests and their related communications should continue to be sent through OSP electronic systems (MyFunding, MyRA, Contraxx, etc.)

For the latest updates from PittResearch, visit https://research.pitt.edu/pitt-researchers/research-operations-during-covid-19-pandemic. For all updates related to the University’s response to the COVID-19 pandemic, please visit www.emergency.pitt.edu/covid-19.

This page was last updated 08/2/2021 1:30 PM

 

OSP is monitoring the release of information related to COVID-19 from the University of Pittsburgh and from funding sponsors, including federal agencies. The information below will continue to be updated.

OSP Communications
E-mail regarding COVID-19 Information (released 03-12-2020) 

Pitt Research

Senior Vice Chancellor for Research Update on Research at Pitt (12-14-2020)
Office of Research Protections Important Update on Tier 3 Studies (11-24-2020)
​Senior Vice Chancellor for Research Update on Tier 3 Research Activities (11-23-2020)
Senior Vice Chancellor for Research Updated Details, Resources for Research Operations During the Pandemic (10-20-2020)
Senior Vice Chancellor for Research Research Restart website (06-10-2020)
Senior Vice Chancellor for Research Research Restart announcement (06-03-2020)
Senior Vice Chancellor for Research Guidelines for Essential Research Personnel  (released 03-25-2020)
Senior Vice Chancellor for Research Coordination of COVID-19 Research at Pitt and UPMC (released 03-23-2020)
Senior Vice Chancellor for Research COVID-19: Status of Clinical Research Operations at Pitt (released 03-16-2020)
Senior Vice Chancellor for Research Pandemic Preparedness Guide for Researchers (released 03-12-2020)
Senior Vice Chancellor for Research Important - Clinical Research operations and COVID-19 (released 03-11-2020)
Senior Vice Chancellor for Research Emergency Page (released 03-11-2020) 
Senior Vice Chancellor for Research COVID-19: Status of Research Operations at Pitt (released 03-11-2020)

University of Pittsburgh
Office of the Chancellor Our plans for being safe on campus (released 06-20-2020)
COVID-19 Update, confirmed case of coronavirus on campus (released 03-22-2020)
Office of Human Resources COVID-19 Workplace Concerns: Resources for Employees (released 03-18-2020)
​Office of the Chancellor A Reduction in Operating Status (released 03-18-2020)
Office of the Chancellor COVID-19 update for faculty and staff (released 03-14-2020)
Office of the Chancellor COVID-19 Pandemic: Pitt's Actions (released 03-10-2020)
Pitt OHR Information Regarding Travel Expense Reimbursement and COVID-19 (released 03-10-2020) 
Public Safety & Emergency Management’s COVID-19 information page (released 03-10-2020)
Pitt IT's Covid-19 Preparation Information (released 03-10-2020)

External Agencies

Funding Opportunities

Agency
Opportunity ID
Sponsor Due Date Posted
Cisco RFP-20-04 Pandemic/COVID19 Science, Technology and Social Impact Rolling 07-19-2020
Department of Education Agency Information Collection Activities; Comment Request; Higher Education Emergency Relief Fund (HEERF) I, II and III Data Collection Form 08-23-2021 06-24-2021
Department of Education American Rescue Plan (ARP) HEERF III

1. Student Aid Portion for Public and Nonprofit Institutions (a)(1): Deadline is August 11, 2021. Application is only required if institution did not receive a HEERF Student Aid Portion award. If you received an award,  ED will make supplemental awards to your existing Student Aid Portion grant and no action is required by your institution to receive these supplemental awards. The Project Director identified on the most current Grant Award Notification (GAN) will automatically receive an email indicating a supplement award is made to your institution.
Allocations table

2. Institutional Portion for Public and Nonprofit Institutions (a)(1): Deadline is August 11, 2021. Application is only required if institution did not receive a HEERF Student Aid Portion award. If you received an award,  ED will make supplemental awards to your existing Institutional Aid Portion grant and no action is required by your institution to receive these supplemental awards. The Project Director identified on the most current GAN will automatically receive an email indicating a supplement award is made to your institution.
Allocations table

3. Proprietary Institutions Grant Funds for Students (a)(4): Deadline is August 11, 2021. Application is required for all Proprietary Institutions, regardless of whether an institution received HEERF awards.
Allocations table

4. FAQs
See text 05-12-2021
Department of Health and Human Services RFA-IP-22-004 US Platform to Measure Effectiveness of Seasonal Influenza, COVID-19 and other Respiratory Virus Vaccines for the Prevention of Acute Illness in Ambulatory Settings 02-01-2022 08-02-2021
Department of Health and Human Services NOT-MD-21-007 Notice of Intent to Publish a Funding Opportunity Announcement for Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities Forecasted Opportunity 06-30-2021
Department of Health and Human Services NOT-AI-21-064 Notice of Intent to Publish a Funding Opportunity Announcement for Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern (U19 Clinical Trial Not Allowed) 10-15-2021 06-30-2021
Department of Health and Human Services ARP-PHIT-21-001 Public Health Informatics & Technology Workforce Development Program (The PHIT Workforce Development Program) 08-11-2021 06-18-2021
Department of Health and Human Services HRSA-21-107 Telehealth Technology-Enabled Learning Program 06-25-2021 05-24-2021
Department of Labor  SHTG-FY-21-05 Workplace Safety and Health Training on Infectious Diseases, Including COVID-19 07-26-2021 06-28-2021
Department of Labor Employment and Training Administration ETA-TEGL-12-19 National Dislocated Worker Grants Program  Rolling 03-19-2020
Department of State SFOP0007088 COVID-19 Private Sector Engagement & Partnership Fund 08-27-2021 05-24-2021
Fast Grants Emergent Ventures: Fast Funding for COVID-19 Science Rolling/Ongoing 04-08-2020
National Center for Advancing Translational Sciences (NCATS) NOT-TR-21-022 Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for the Clinical and Translational Science Award (CTSA) Program to Address COVID-19 Public Health Needs 08-17-2024 03-01-2021
National Center for Advancing Translational Sciences (NCATS) NOT-TR-21-017 Notice of Special Interest (NOSI): Administrative Supplements for the Clinical and Translational Science Award (CTSA) Program to Address COVID-19 Public Health Needs Rolling through 08-16-2024 02-05-2021
National Center for Advancing Translational Sciences (NCATS) NOT-TR-20-016 Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements for Tissue Chips Research on the 2019 Novel Coronavirus Rolling through 01-26-2022 04-09-2020
National Heart, Lung, and Blood Institute (NHLBI) NOT-HL-21-018 Request for Information (RFI): Input on Technologies and Approaches that can Identify Individuals Susceptible to Developing Post-Acute-Sequelae of SARS-CoV-2 infection (PASC) 08-27-2021 07-23-2021
National Institute on Aging (NIA) NOT-AG-21-016 Notice of Special Interest (NOSI): Neurological and Neurocognitive Sequelae from SARS-CoV-2 Infection and COVID-19 in Aging and Age-Related Neurodegeneration 05-08-2023 03-01-2021
National Institute on Alcohol Abuse and Alcoholism (NIAAA) NOT-AA-21-041 Notice of Clarification of Responsiveness to NIAAA RFA-AA-21-004 "SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trial Not Allowed)" 08-17-2021 07-19-2021
National Institute on Alcohol Abuse and Alcoholism (NIAAA) NOT-AA-21-040 Notice of Clarification of Responsiveness to NIAAA RFA-AA-21-003 "SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R03 Clinical Trial Not Allowed)" 08-17-2021 07-19-2021
National Institute on Alcohol Abuse and Alcoholism (NIAAA) NOT-AA-21-039 Notice of Clarification of Responsiveness to NIAAA RFA-AA-21-002 "SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trial Not Allowed)" 08-17-2021 07-19-2021
National Institute of Allergy and Infectious Diseases (NIAID) PAR-21-276 Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed) Rolling 07-19-2021
National Institute of Allergy and Infectious Diseases (NIAID) NOT-AI-21-061 Notice to Extend Eligibility for Submission of K99/R00 Pathway to Independence Award Applications (and Physician-Scientist K99/R00) due to COVID–related Disruptions Various through July 2022 07-02-2021
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) NOT-AR-21-012 Notice of Special Interest: Promoting Research on COVID-19 and Rheumatic, Musculoskeletal and Skin Diseases 11-18-2021 01-08-2021
National Institute of Biomedical Imaging and Biomedical Engineering NIH POCTRN Fast-Track Program for COVID-19 Test Development and Distribution Rolling 05-15-2020
National Institute of Child Health and Human Development (NICHD) NOT-HD-21-037 Notice of Special Interest (NOSI): Competitive Revision and Administrative Supplements to Existing NICHD HIV Grants and Cooperative Agreements to Understand HIV Health Impacts of COVID-19 
AIDS Application Due Date(s) – September 7, 2021, January 7, 2022, May 7, 2022, by 5:00 PM local time of applicant organization. Applications received after the designated receipt dates will not be considered.
Various 07-02-2021
National Institute of Child Health and Human Development (NICHD) NOT-HD-21-026 Notice of Special Interest (NOSI): Research on the Impact of the Covid 19 Pandemic and Risks for Abuse and Injury Among Vulnerable Children and Youth 05-08-2024 05-03-2021
National Institute of Diabetes and Digestive and Kidney Diseases  NOT-DK-21-019 NIDDK Notice of Continuation of Temporary Extension of Eligibility for the NIH Mentored Research Scientist Development Award (K01) Award During the COVID-19 Pandemic
NIDDK will be extending the two-receipt cycle extension (roughly eight additional months) of eligibility for prospective applicants meeting the requirements for submission of a K01 application from the time period covered by the June/July 2021 due dates through the October/November 2021 due dates. Such individuals will be permitted to submit applications up to the February/March, 2022 and June/July, 2022 due dates, respectively.
See text 05-24-2021
National Institute on Drug Abuse (NIDA) NOT-DA-21-041 Notice of Special Interest (NOSI) Announcing the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus 03-31-2022 04-19-2021
National Institute on Drug Abuse (NIDA) NOT-DA-21-017 Notice of Special Interest (NOSI): Medical Consequences of Smoking and Vaping Drugs of Abuse in Individuals with HIV and COVID-19
This notice applies to due dates on or after May 5, 2021 and subsequent receipt dates through September 7, 2024. 
See text 02-08-2021
National Institute on Drug Abuse (NIDA) NOT-DA-21-018 Notice of Special Interest (NOSI): Long-Term Neurocognitive Consequences of COVID-19 in Individuals Living with HIV and Substance Use Disorders
This notice applies to due dates on or after May 7, 2021 and subsequent receipt dates through September 7, 2024
See text 02-05-2021
National Institute of General Medical Sciences NOT-GM-21-019 Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions for Modeling Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 12/16/2021 03/01/2021
National Institute of Mental Health (NIMH) NOT-MH-21-225 Notice of Special Interest (NOSI): COVID-19 Related School Disruptions Impact on Mental Health, Cognitive, Social, and Emotional Development of Children 09-08-2022 04-05-2021
National Institute of Neurological Disorders and Stroke NOT-NS-20-074 Notice of Change to Eligible Activity Codes for NOT-NS-20-051 "Notice of Special Interest: Availability of Urgent Competitive Revisions and Administrative Supplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System" N/A 05-27-2020
National Institute on Deafness and Other Communication Disorders (NIDCD) NOT-DC-20-006 Notice of Eligibility Change for NIDCD Urgent Competitive Revisions and Administrative Supplements for Research on COVID-19 N/A 04-22-2020
NIH NOT-AA-21-040 Notice of Clarification of Responsiveness to NIAAA RFA-AA-21-003 "SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R03 Clinical Trial Not Allowed)" 08-17-2021 07-19-2021
NIH PAR-21-275 The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional) varies 06-28-2021
NIH NOT-AI-21-057 Notice of Special Interest (NOSI) HIV/AIDS in the Era of COVID-19: When Pandemics Collide 09-07-2021 06-28-2021
NIH PA-21-232 Comprehensive Care for Adults with Type 2 Diabetes Mellitus from Populations with Health Disparities (R01 Clinical Trial Optional) Various, see notice 05-28-2021
NIH RFA-DA-22-007 Mechanistic Studies on the Impact of Social Inequality on the Substance Use Trajectory (R01 Clinical Trial Not Allowed) 10-14-2021 05-28-2021
NIH RFA-DA-22-024 Mechanistic Studies on the Impact of Social Inequality on the Substance Use Trajectory (R01 Basic Experimental Studies with Humans Required) 10-14-2021 05-28-2021
NIH RFA-DA-22-005 Mechanistic studies on the impact of social inequality on the substance use trajectory (R21 - Clinical Trial Not Allowed) 10-14-2021 05-28-2021
NIH RFA-DA-22-030 Mechanistic Studies on the Impact of Social Inequality on the Substance Use Trajectory (R21 - Basic Experimental Studies with Humans Required) 10-14-2021 05-28-2021
NIH NOT-OD-21-125 Notice of Correction to NOT-OD-21-103, "Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-engaged COVID-19 Testing Interventions among Underserved and Vulnerable Populations – RADx-UP Phase II (Emergency Supplement - Clinical Trial Optional)   05-18-2021
NIH NOT-HD-21-026 Notice of Special Interest (NOSI): Research on the Impact of the Covid 19 Pandemic and Risks for Abuse and Injury Among Vulnerable Children and Youth 05-31-2024 04-27-2021
NIH RFA-OD-21-009 Emergency Award: RADx-UP - Social, Ethical, and Behavioral Implications (SEBI) Research on Disparities in COVID-19 Testing among Underserved and Vulnerable Populations (U01 Clinical Trials Optional) 07-07-2021 04-19-2021
NIH RFA-OD-21-008 Emergency Awards: Community-engaged COVID-19 Testing Interventions among Underserved and Vulnerable Populations RADx-UP Phase II (U01 Clinical Trial Optional) 07-07-2021 04-19-2021
NIH NOT-OD-21-106 Continuation of Temporary Extension of Eligibility for the NIH K99/R00 Pathway to Independence Award During the COVID-19 Pandemic Varies through July 2022 04-19-2021
NIH RFA-OD-21-009 Emergency Award: RADx-UP - Social, Ethical, and Behavioral Implications (SEBI) Research on Disparities in COVID-19 Testing among Underserved and Vulnerable Populations (U01 Clinical Trials Optional) 07-07-2021 04-14-2021
NIH RFA-OD-21-008 Emergency Awards: Community-engaged COVID-19 Testing Interventions among Underserved and Vulnerable Populations RADx-UP Phase II (U01 Clinical Trial Optional) 07-07-2021 04-14-2021
NIH NOT-OD-21-095 Extending the Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic: January 2022 Council 05-25-2021 04-05-2020
NIH NOT-MH-21-225 Notice of Special Interest (NOSI): COVID-19 Related School Disruptions Impact on Mental Health, Cognitive, Social, and Emotional Development of Children N/A 03-31-2021
NIH NOT-OD-21-052 Reminder – Requesting Extensions for Early Career Scientists Whose Career Trajectories Have Been Significantly Impacted by COVID-19   02-08-2021
NIH NOT-DA-21-011 Notice of Special Interest (NOSI): Effects of smoking and vaping on the risk and outcome of COVID-19 infection 09-08-2024 01-26-2021
NIH NOT-AG-21-015 Notice of Special Interest (NOSI): Aging-Relevant Behavioral and Social Research on Coronavirus Disease 2019 (COVID-19) 05-08-2023 01-26-2021
NIH NOT-DE-21-001 Notice of Special Interest (NOSI): NIDCR Support for Research on the Physiological Involvement of Oral Cavity in Coronavirus Disease 2019 (COVID-19) This notice applies to due dates on or after June 5, 2021 and subsequent receipt dates through May 8, 2023. 05-08-2023 01-26-2021
NIH NOT-HD-20-031 Notice of Special Interest (NOSI) – Research on Rehabilitation Needs Associated with the COVID-19 Pandemic 05-08-2023 10-02-2020
NIH NOT-NS-21-004 Notice of Temporary Extension of Eligibility for the BRAIN Initiative Diversity K99/R00 Career Transition Award During the COVID-19 Pandemic Various through Nov 2021 10-02-2020
NIH NOT-OD-20-179 Extending the Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic: August/October 2021 Councils 30 days prior to session date 10-02-2020
NIH PAR-20-312 State Occupational Safety and Health Surveillance Program (U60)
Letter of Intent Due Date(s): 10-20-2020, 08-10-2021, 8-10-2022
Application Due Date(s): 12-16-2020, 09-14-2021, 09-14-2022
See Text 09-29-2020
NIH NOT-OD-20-168 Notice of Change: Expansion of Research Scope of RFA-OD-19-029 “The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional)" 11-26-2021 09-15-2020
NIH New Emergency Opportunity Funds PPE for COVID-19 Clinical Research Rolling until 07-28-2021 07-15-2020
NIH NOT-HS-20-007 Notice of Intent: Revision Supplements to Existing AHRQ Grants and Cooperative Agreements to Address Health System Responsiveness to COVID-19  N/A 03-26-2020
NIH NOT-HS-20-008 Notice of Intent: New Funding Opportunity Announcement to Support Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19  N/A 03-26-2020
Oak Ridge National Laboratory Rapid Access Proposal for COVID-19 Research Rolling 04-08-2020
Xsede  COVID-19 High Performance Computing Consortium Rolling 03-24-2020
U.S. Food and Drug Administration (FDA) FOR-FD-22-001 Innovation Grant: COVID-19 and Health Equity (R01) Clinical Trials Optional 03-31-2022 (Estimated) 06-15-2021
US Economic Development Administration EDA CARES Act Recovery Assistance
1. EDA CARES Act Overview Webinar Recording
2. EDA CARES Act Non-Competitive Awards Overview Webinar Recording
Rolling 05-07-2020
USDA The Business and Industry Coronavirus Aid, Relief, and Economic Security Act (CARES Act) Guaranteed Loan Program 09-25-2021 05-22-2020